Tehnik v proizvodnji farmacevtskih učinkovin (m/ž/d) Temporary (Fixed Term) Slovenia Mengeš Dec 04, 2025 ...
Bli en del av Novartis, här kan du se mer om vilka karriärmöjligheter som finns.
Novartis heeft wereldwijd zowat 119.000 medewerkers waarvan er 2000 in België werken. Het aantrekken van getalenteerde mensen, hen ontwikkelen en behouden is van cruciaal belang voor ons. Daarmee ...
Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz and Advanced Accelerator Applications to learn about our generics and radiopharmaceutical ...
Asciminib (Scemblix®) nun auch zur Behandlung erwachsener Patient*innen mit neu diagnostizierter CML zugelassen1Zulassung basiert auf Ergebnissen der Phase-III ...
Basel, November 20, 2025 – Novartis today rolled forward its mid-term guidance to 2025-2030 with a sales CAGR of +5-6% cc. The updated outlook will be featured at its Meet Novartis Management event in ...
ノバルティス ファーマ株式会社（本社：東京都港区、代表取締役社長：ジョンポール・プリシーノ、以下「ノバルティス ファーマ」）は、本日、眼科用血管内皮増殖因子（VEGF）阻害剤 ...
Εξερευνήστε ευκαιρίες στη Novartis παρακάτω. Expert Scientific Writer Regular, Full time Development Ireland Dublin (NOCC) Δεκ 08, 2025 Associate Director, Global Publications & Foundational Content ...
Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030 Marks latest milestone in company’s previously announced $23 billion ...
Sports have a universal appeal that transcends boundaries. Each weekend, the National Football League (NFL) ignites millions of passionate fans from across the country, demonstrating the deep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback